Tumor cells, but not endothelial cells, mediate eradication of primary sarcomas by stereotactic body radiation therapy
Author(s) -
Everett J. Moding,
Katherine D. Castle,
Bradford A. Perez,
Patrick Oh,
Hooney Min,
Hannah Norris,
Yan Ma,
Diana M. Cardona,
ChangLung Lee,
David G. Kirsch
Publication year - 2015
Publication title -
science translational medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.819
H-Index - 216
eISSN - 1946-6242
pISSN - 1946-6234
DOI - 10.1126/scitranslmed.aaa4214
Subject(s) - cancer research , sarcoma , radiation therapy , genetic enhancement , radiosensitivity , medicine , endothelial stem cell , bystander effect , biology , pathology , immunology , gene , genetics , in vitro
Tumor cells, rather than endothelial cells, are critical targets that regulate primary sarcoma eradication by radiation therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom